These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 18949417)
1. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer. Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846 [TBL] [Abstract][Full Text] [Related]
3. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil. Zheng Z; Li J; He X; Chen X; Yu B; Ji J; Zhang J; Wang T; Gu Q; Zhu Z; Liu B Hepatogastroenterology; 2010; 57(102-103):1106-12. PubMed ID: 21410040 [TBL] [Abstract][Full Text] [Related]
4. Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. Wong CS; Wong VW; Chan CM; Ma BB; Hui EP; Wong MC; Lam MY; Au TC; Chan WH; Cheuk W; Chan AT Oncol Rep; 2008 Jul; 20(1):89-98. PubMed ID: 18575723 [TBL] [Abstract][Full Text] [Related]
5. Suppression of heat shock protein 27 expression promotes 5-fluorouracil sensitivity in colon cancer cells in a xenograft model. Hayashi R; Ishii Y; Ochiai H; Matsunaga A; Endo T; Hasegawa H; Kitagawa Y Oncol Rep; 2012 Oct; 28(4):1269-74. PubMed ID: 22842517 [TBL] [Abstract][Full Text] [Related]
6. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines. McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143 [TBL] [Abstract][Full Text] [Related]
7. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433 [TBL] [Abstract][Full Text] [Related]
8. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. De Angelis PM; Svendsrud DH; Kravik KL; Stokke T Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Adamsen BL; Kravik KL; Clausen OP; De Angelis PM Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Heat-shock Protein 27 Reduces 5-Fluorouracil-acquired Resistance in Human Colon Cancer Cells. Asada Y; Tsuruta M; Okabayashi K; Shigeta K; Ishida T; Shimada T; Suzumura H; Koishikawa K; Akimoto S; Hasegawa H; Kitagawa Y Anticancer Res; 2021 Mar; 41(3):1283-1290. PubMed ID: 33788719 [TBL] [Abstract][Full Text] [Related]
11. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro. Rocchi P; Jugpal P; So A; Sinneman S; Ettinger S; Fazli L; Nelson C; Gleave M BJU Int; 2006 Nov; 98(5):1082-9. PubMed ID: 16879439 [TBL] [Abstract][Full Text] [Related]
12. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine. Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811 [TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 27 knockdown using nucleotide‑based therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells. Shimada T; Tsuruta M; Hasegawa H; Okabayashi K; Shigeta K; Ishida T; Asada Y; Suzumura H; Koishikawa K; Akimoto S; Kitagawa Y Oncol Rep; 2018 Mar; 39(3):1119-1124. PubMed ID: 29328475 [TBL] [Abstract][Full Text] [Related]
14. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells. Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326 [TBL] [Abstract][Full Text] [Related]
15. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein. He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis for the induction of an angiogenesis inhibitor, thrombospondin-1, by 5-fluorouracil. Zhao HY; Ooyama A; Yamamoto M; Ikeda R; Haraguchi M; Tabata S; Furukawa T; Che XF; Zhang S; Oka T; Fukushima M; Nakagawa M; Ono M; Kuwano M; Akiyama S Cancer Res; 2008 Sep; 68(17):7035-41. PubMed ID: 18757417 [TBL] [Abstract][Full Text] [Related]
17. Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells. Wu X; Deng Y; Wang G; Tao K J Surg Res; 2007 Mar; 138(1):56-63. PubMed ID: 17169374 [TBL] [Abstract][Full Text] [Related]
18. Cell cycle perturbation and acquired 5-fluorouracil chemoresistance. Guo X; Goessl E; Jin G; Collie-Duguid ES; Cassidy J; Wang W; O'Brien V Anticancer Res; 2008; 28(1A):9-14. PubMed ID: 18383818 [TBL] [Abstract][Full Text] [Related]
19. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols. De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks. Wang W; McLeod HL; Cassidy J; Collie-Duguid ES Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]